高危输卵管-卵巢癌人群的输卵管切除术:共识与预防措施
本文为临床意见文章,讨论高危人群(如BRCA1、BRCA2等基因致病变异者)接受降低风险输卵管切除术后延迟卵巢切除术的策略。文章指出该策略可改善绝经相关生活质量并减少癌症担忧,但其降低癌症风险的有效性尚未确立,强调应尽可能在临床试验中提供该方案。
要点
- 高危人群接受降低风险输卵管卵巢切除术可降低死亡率,但绝经前卵巢切除影响生活质量。
- 输卵管切除术加延迟卵巢切除术可改善绝经相关生活质量并减少癌症担忧。
- 该策略降低癌症风险的有效性尚未确立,应尽可能在临床试验中提供。
核心结论
- 降低风险输卵管切除术加延迟卵巢切除术与改善绝经相关生活质量和减少癌症担忧相关,但其降低癌症风险的有效性尚未确立。
- 应尽可能在临床试验中提供降低风险输卵管切除术加延迟卵巢切除术。
研究设计与样本
- 本文为临床意见文章,讨论高危输卵管-卵巢癌人群的预防策略,未报告系统检索方法或样本量。
主要发现
- 输卵管-卵巢癌尤其是高级别浆液性癌是致死性妇科恶性肿瘤之一,主要因晚期诊断且缺乏有效筛查策略。
- 美国国家综合癌症网络(NCCN)推荐携带BRCA1、BRCA2、RAD51C、RAD51D、BRIP1、PALB2及Lynch综合征相关基因致病变异的高危个体接受降低风险输卵管卵巢切除术,该手术已显示可降低死亡率。
- 绝经前卵巢切除术可导致显著生活质量损害,许多高危个体因此延迟或放弃降低风险输卵管卵巢切除术。
- 大多数高级别浆液性癌起源于输卵管,引发对降低风险输卵管切除术加延迟卵巢切除术这一新型预防策略的兴趣。
- 降低风险输卵管切除术加延迟卵巢切除术与改善绝经相关生活质量和减少癌症担忧相关,但其降低癌症风险的有效性尚未确立。
关键数值与推荐
- 美国国家综合癌症网络(NCCN)推荐携带BRCA1、BRCA2、RAD51C、RAD51D、BRIP1、PALB2及Lynch综合征相关基因致病变异的高危个体接受降低风险输卵管卵巢切除术。
临床怎么用
- 作者认为应尽可能在临床试验中提供降低风险输卵管切除术加延迟卵巢切除术。
局限性
- 降低风险输卵管切除术加延迟卵巢切除术降低癌症风险的有效性尚未确立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tubo-ovarian carcinoma, particularly high-grade serous carcinoma, is one of the most lethal gynecologic malignancies, largely due to its late-stage diagnosis and lack of effective screening strategies. For individuals with hereditary pathogenic variants in genes associated with ovarian cancer such as BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2, and Lynch syndrome-associated genes, the National Comprehensive Cancer Network recommends risk-reducing salpingo-oophorectomy, which has been shown to decrease mortality. However, premenopausal oophorectomy can result in substantial quality-of-life impairments, and as a result, many high-risk individuals delay or forego risk-reducing salpingo-oophorectomy despite its proven mortality benefit. The discovery that most high-grade serous carcinomas originate in the fallopian tubes has led to interest in a novel preventive strategy: risk-reducing salpingectomy followed by delayed oophorectomy in high-risk individuals. In this clinical opinion, we describe that while risk-reducing salpingectomy with delayed oophorectomy has been associated with improved menopause-related quality of life and reduced cancer worry, its efficacy in cancer risk reduction has not been established. We explain the importance of offering risk-reducing salpingectomy with delayed oophorectomy within clinical trials whenever possible.
引用
- Wilke RN, Pennington KP, Gootzen TA, et al. Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution. Am J Obstet Gynecol. 2025. PMID: 41183726. doi:10.1016/j.ajog.2025.10.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。